ZA200904200B - 4-(Heterocyclyl)Alkyl-N-(Arylsulfonyl) Indole compounds and their use as 5-HT6 Ligands - Google Patents
4-(Heterocyclyl)Alkyl-N-(Arylsulfonyl) Indole compounds and their use as 5-HT6 LigandsInfo
- Publication number
- ZA200904200B ZA200904200B ZA200904200A ZA200904200A ZA200904200B ZA 200904200 B ZA200904200 B ZA 200904200B ZA 200904200 A ZA200904200 A ZA 200904200A ZA 200904200 A ZA200904200 A ZA 200904200A ZA 200904200 B ZA200904200 B ZA 200904200B
- Authority
- ZA
- South Africa
- Prior art keywords
- arylsulfonyl
- heterocyclyl
- ligands
- alkyl
- indole compounds
- Prior art date
Links
- 150000002475 indoles Chemical class 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN44CH2007 | 2007-01-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200904200B true ZA200904200B (en) | 2010-10-27 |
Family
ID=38819780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200904200A ZA200904200B (en) | 2007-01-08 | 2009-06-15 | 4-(Heterocyclyl)Alkyl-N-(Arylsulfonyl) Indole compounds and their use as 5-HT6 Ligands |
Country Status (18)
Country | Link |
---|---|
US (1) | US20100041669A1 (fr) |
EP (1) | EP2121602B1 (fr) |
JP (1) | JP2010515673A (fr) |
KR (1) | KR101176894B1 (fr) |
CN (1) | CN101563321B (fr) |
AU (1) | AU2007343062B2 (fr) |
BR (1) | BRPI0718736A2 (fr) |
CA (1) | CA2672190C (fr) |
DK (1) | DK2121602T3 (fr) |
EA (1) | EA016015B1 (fr) |
ES (1) | ES2533902T3 (fr) |
HK (1) | HK1135986A1 (fr) |
IL (1) | IL199300A (fr) |
MX (1) | MX2009006757A (fr) |
NO (1) | NO341958B1 (fr) |
NZ (1) | NZ578281A (fr) |
WO (1) | WO2008084491A1 (fr) |
ZA (1) | ZA200904200B (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8318725B2 (en) | 2008-09-17 | 2012-11-27 | Suven Life Sciences Limited | Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands |
JP6454346B2 (ja) | 2013-12-20 | 2019-01-16 | サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. | 芳香族複素環式化合物及び医薬におけるその応用 |
CN105541693B (zh) * | 2014-07-08 | 2018-10-16 | 广东东阳光药业有限公司 | 芳杂环类衍生物及其在药物上的应用 |
EP3530651A1 (fr) * | 2018-02-21 | 2019-08-28 | Adamed sp. z o.o. | Dérivés de l'indole et du benzimidazole comme antagonistes doubles des récepteurs 5-ht2a et 5-ht6 |
CN111233736B (zh) * | 2020-03-16 | 2021-07-16 | 东莞市东阳光新药研发有限公司 | 芳杂环类衍生物的盐及其用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9820113D0 (en) * | 1998-09-15 | 1998-11-11 | Merck Sharp & Dohme | Therapeutic agents |
EP1343756A2 (fr) * | 2000-11-02 | 2003-09-17 | Wyeth | 1-aryl- ou 1-alkylsulfonyl-heterocyclylbenzazoles en tant que ligands de 5-hydroxytryptamine-6 |
NZ529631A (en) * | 2001-06-07 | 2006-08-31 | F | Indole derivatives with 5-hydroxytryptamine (5-HT) 5-HT6 receptor affinity in the treatment of disorders of the CNS |
US7875605B2 (en) * | 2002-11-28 | 2011-01-25 | Suven Life Sciences Limited | N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
SE0302760D0 (sv) * | 2003-10-20 | 2003-10-20 | Biovitrum Ab | New compounds |
AU2007271188B2 (en) * | 2006-07-03 | 2012-11-01 | Proximagen Limited | Indoles as 5-HT6 modulators |
-
2007
- 2007-07-26 BR BRPI0718736-0A2A patent/BRPI0718736A2/pt not_active Application Discontinuation
- 2007-07-26 AU AU2007343062A patent/AU2007343062B2/en not_active Ceased
- 2007-07-26 EP EP07827524.5A patent/EP2121602B1/fr active Active
- 2007-07-26 CN CN200780047442XA patent/CN101563321B/zh not_active Expired - Fee Related
- 2007-07-26 WO PCT/IN2007/000311 patent/WO2008084491A1/fr active Application Filing
- 2007-07-26 DK DK07827524T patent/DK2121602T3/en active
- 2007-07-26 NZ NZ578281A patent/NZ578281A/en not_active IP Right Cessation
- 2007-07-26 KR KR1020097014150A patent/KR101176894B1/ko active IP Right Grant
- 2007-07-26 CA CA2672190A patent/CA2672190C/fr not_active Expired - Fee Related
- 2007-07-26 EA EA200970554A patent/EA016015B1/ru not_active IP Right Cessation
- 2007-07-26 MX MX2009006757A patent/MX2009006757A/es active IP Right Grant
- 2007-07-26 US US12/521,984 patent/US20100041669A1/en not_active Abandoned
- 2007-07-26 ES ES07827524.5T patent/ES2533902T3/es active Active
- 2007-07-26 JP JP2009544494A patent/JP2010515673A/ja active Pending
-
2009
- 2009-06-11 IL IL199300A patent/IL199300A/en active IP Right Grant
- 2009-06-15 ZA ZA200904200A patent/ZA200904200B/xx unknown
- 2009-06-24 NO NO20092400A patent/NO341958B1/no not_active IP Right Cessation
-
2010
- 2010-03-16 HK HK10102714.9A patent/HK1135986A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO341958B1 (no) | 2018-03-05 |
EA016015B1 (ru) | 2012-01-30 |
WO2008084491A1 (fr) | 2008-07-17 |
EP2121602B1 (fr) | 2015-03-18 |
BRPI0718736A2 (pt) | 2014-03-25 |
EA200970554A1 (ru) | 2009-12-30 |
DK2121602T3 (en) | 2015-04-07 |
MX2009006757A (es) | 2009-06-30 |
ES2533902T3 (es) | 2015-04-15 |
KR101176894B1 (ko) | 2012-08-30 |
EP2121602A1 (fr) | 2009-11-25 |
NZ578281A (en) | 2011-01-28 |
CN101563321A (zh) | 2009-10-21 |
US20100041669A1 (en) | 2010-02-18 |
JP2010515673A (ja) | 2010-05-13 |
IL199300A (en) | 2014-03-31 |
KR20090096513A (ko) | 2009-09-10 |
HK1135986A1 (fr) | 2010-06-18 |
CA2672190A1 (fr) | 2008-07-17 |
AU2007343062A1 (en) | 2008-07-17 |
CA2672190C (fr) | 2013-02-05 |
AU2007343062B2 (en) | 2011-02-10 |
NO20092400L (no) | 2009-10-02 |
CN101563321B (zh) | 2012-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201308294B (en) | Heterocyclic compounds and their uses | |
EP2264017A4 (fr) | Dérivé hétérocyclique et son utilisation | |
ZA201004305B (en) | Quinoline derivatives and their use as fungicides | |
IL210412A0 (en) | Heterocyclic derivatives and uses thereof | |
HK1150274A1 (zh) | 稠合的雜環衍生物及其用途 | |
ZA201202489B (en) | Novel heterocyclic acrylamides and their use as pharmaceuticals | |
HK1137027A1 (en) | Pyrrolo-nitrogenous heterocyclic derivatives and the pharmaceutical use thereof | |
IL202034A0 (en) | Heterocyclic indazole derivatives | |
IL207846A0 (en) | Arylsulfonyl pyrazoline carboxaidine derivatives as 5-ht6 antagonists | |
IL201830A0 (en) | Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials | |
ATE537149T1 (de) | Sulfonyl-pyrazolinyl-1-carboxamidinderivate als 5-ht6-antagonisten | |
EP2089392A4 (fr) | Dérivés de 3-(dihydro-1h-pyrazolo ý4,3-d¨pyrimidin-5-yl)-4-propoxybenzènesulfonamide et procédés d'utilisation | |
PL2238119T3 (pl) | Chinazoliny i pokrewne związki heterocykliczne i ich zastosowanie terapeutyczne | |
ZA200905671B (en) | Heterocyclic compounds, compositions comprising them and methods of their use | |
ATE555785T1 (de) | Triazolderivate als smo-antagonisten | |
ZA201103462B (en) | Aryl piperazine and their use as alpha2c antagonists | |
BRPI0821142A2 (pt) | derivados heterocíclicos bicíclicos | |
ATE544752T1 (de) | Aryloxyacetamidderivate und ihre verwendung als fungizide | |
ATE547407T1 (de) | Alkylthiopyrimidine als crth2-antagonisten | |
HK1158640A1 (en) | Substituted 6-(1-piperazinyl)-pyridazines as 5-ht6 receptor antagonists 5-ht6 6-(1-)- | |
ZA201002580B (en) | Heterocyclic derivatives | |
ZA200904200B (en) | 4-(Heterocyclyl)Alkyl-N-(Arylsulfonyl) Indole compounds and their use as 5-HT6 Ligands | |
IL202339A0 (en) | Azacyclylbenzamide derivatives as histamine-3 antagonists | |
ATE512137T1 (de) | Benzoylpiperidinderivate als doppelmodulatoren des 5-ht2a- und des d3-rezeptors | |
ZA201203631B (en) | New phenylhydrazone derivatives and their use as pharmaceuticals |